- Home
- / Yantai Dongcheng Pharmaceutical Group
Yantai Dongcheng Pharmaceutical Group
Stock Price
¥13.1
2024-10-29
Market Capitalization
¥10.6 B
2024-10-29
Revenue
¥2.7 B
FY, 2025
Yantai Dongcheng Pharmaceutical Group Summary
Company Summary
- Overview
- Yantai Dongcheng Pharmaceutical Group (烟台东诚药业集团股份有限公司, formerly Yantai Dongcheng Biochemical) is a company that produces chemicals and provides biotechnology services. It offers heparin API, chondroitin sulfate, anticoagulants, and nuclide drugs.
- Type
- Public
- Status
- Active
- Founded
- 1998
- HQ
- Yantai, CN | view all locations
- Website
- https://www.dcb-group.com/
- Cybersecurity rating
Table of Contents
Key People
Zhigang Luo, General Manager, Director
Xiaojie Liu, Deputy General Manager, Secretary of the Board, Director
Xiaoming Wu, Deputy General Manager
LocationsView all
1 location detected
Yantai, Shan Dong Sheng HQ
China
No.7 ChangBaiShan Road, Yantai Development Zone
Yantai Dongcheng Pharmaceutical Group Financials
Summary Financials
- Revenue (FY, 2025)
- ¥2.7B
- Gross profit (FY, 2025)
- ¥1.4B
- Net income (FY, 2025)
- ¥154.4M
- Cash (FY, 2025)
- ¥844.7M
- EBIT (FY, 2025)
- ¥375.2M
- Enterprise value
- $12.5B
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026